We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
It reduced the risk of cardiovascular death or hospitalisation for heart failure versus placebo on top of standards of care in adults with heart failure with reduced ejection fraction.